tirzepatide direct from lilly Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth Eli Lilly launches service to

Description

is supported by funds from the Ministry of Education and Science of Poland within the project 'Excellence Initiative - Research University', the Ministry of Health of Poland within the project 'Center of Artificial Intelligence in Medicine at the Medical University of Bialystok', and the Medical Research Agency within the project 'Regional Center for Digital Medicine at the Medical University of Bialystok' (grant number 2023/ABM/02/00008)

But some people may feel uncomfortable or need to stop the medicine if the side effects are serious

The 98-participant trial used liver fat measured by MRI-PDFF as the primary endpoint at 24 weeks and reported statistically significant mean relative reductions in liver fat across retatrutide groups relative to placebo, which the authors characterized as hypothesis-generating